Stockchase Opinions

Jim Cramer - Mad Money Inovio Pharmaceuticals INO-Q DON'T BUY Apr 28, 2021

It's a spec stock that hasn't delivered.
$7.055

Stock price when the opinion was issued

Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

RISKY
A smaller pharma name. It's a pure spec stock. If you're a young investor, it doesn't hurt to hold one spec stock.
COMMENT

It is too small and volatile.